Cite
HARVARD Citation
Carlet, M. et al. (2023). X‐linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL. EMBO molecular medicine. 15 (1), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Carlet, M. et al. (2023). X‐linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL. EMBO molecular medicine. 15 (1), p. n/a. [Online].